© Reuters. FILE PHOTO: A well being official attracts a dose of the AstraZeneca’s COVID-19 vaccine manufactured by the Serum Institute of India, at Infectious Diseases Hospital in Colombo
(Reuters) – Some countries are proscribing use of the AstraZeneca (NASDAQ:) COVID-19 vaccine to sure age teams, or suspending use, after European and British regulators confirmed attainable hyperlinks to uncommon blood clots.
Johnson & Johnson (NYSE:)’s single-shot vaccine has additionally been hit by issues over blood clots. European regulators are reviewing such circumstances and are anticipated to difficulty findings on April 20. U.S. federal well being businesses beneficial pausing its use briefly on April 13 and a U.S. well being advisory panel will meet on April 23 to debate whether or not the pause ought to proceed.
J&J has said that no clear causal relationship has been established between the clots and its vaccine.
The developments pose a danger to vaccination plans in Europe, the place authorities have up to now maintained that the advantages of the AstraZeneca and J&J photographs outweigh dangers.
As of April 4, the European Medicines Agency had acquired experiences of 169 circumstances of cerebral venous sinus thrombosis, after 34 million doses of the AstraZeneca vaccine had been given within the European Economic Area. Canada and Australia have additionally reported some circumstances.
ASTRAZENECA VACCINE BEING USED, WITH OR WITHOUT RESTRICTIONS
Said on April 8 it recommends individuals underneath 50 ought to get Pfizer (NYSE:)’s COVID-19 vaccine as opposed to that of AstraZeneca.
Has resumed use.
Authorities mentioned they might not limit use of the vaccine, saying advantages outweigh dangers.
Vaccination committee has mentioned an alternate must be given for individuals underneath 30 the place attainable, however individuals ought to proceed to have a second shot if they’ve acquired a primary dose of the vaccine.
Resumed inoculations on March 19.
Resumed vaccinations from March 19.
Authorities mentioned in early April they might pause providing the vaccine to individuals underneath 55 and require a brand new evaluation of the shot.
Suspended use of the vaccine for individuals underneath 60 on April 7.
Approved resumption of the vaccine on March 19 however mentioned it must be given solely to individuals aged 55 and over. On April 9, beneficial that recipients of a primary dose of the AstraZeneca shot who’re underneath 55 ought to obtain a second dose with a messenger RNA vaccine.
Resumed utilizing the AstraZeneca vaccine from March 29 for individuals aged 65 and over.
Limited use of the vaccine following the demise of a nurse, and vaccinations will proceed solely in full-fledged medical centres, Russian information company TASS reported on March 19.
On March 31, issued steering to limit use of the vaccine to these aged over 60. On April 1, vaccine fee beneficial individuals underneath 60 who’ve had a primary shot of the vaccine ought to obtain a special product for his or her second dose.
Continuing the vaccine’s rollout.
Resumed use on March 25 after suspending it on March 11.
Resumed utilizing the vaccine on March 22 however warned towards its use in individuals with a low blood platelet rely.
On April 12, the nation mentioned it was proscribing use of the vaccine to these over 60.
Has beneficial the vaccine be used just for individuals over 60, the nation’s high well being adviser mentioned.
Resumed administering the vaccine from March 19.
Restarted use on March 19.
Drug regulator Cofepris mentioned on April 7 it didn’t “at this time” plan to limit the vaccine’s use however was investigating the information raised by Britain.
Limited use of the vaccine to individuals over 60, the federal government mentioned on April 8.
Health minister mentioned on March 31 the vaccine could be restricted to individuals aged over 60 as a precautionary measure.
Will resume administering the vaccine to individuals under 60 years of age, well being officers mentioned on Monday after having briefly suspended use on April 8. [nL1N2MC0AK]
Has resumed use of the vaccine after briefly stopping use of 1 batch on March 11.
Resumed use of the shot for individuals aged 30 or older on April 12. On April 7, had suspended offering the shot to individuals underneath 60.
From April 8, it was giving the vaccine solely to individuals over 60.
Resumed use of the vaccine on March 25 for individuals aged 65 and older.
Began use on March 15 after delaying rollout the week earlier than.
COUNTRIES WHERE ASTRAZENECA VACCINE USE IS SUSPENDED
Suspended administration of the vaccine it was scheduled to obtain on March 20 as a part of the worldwide vaccines-sharing scheme COVAX, the well being ministry mentioned.
In a world first, Denmark determined to cease utilizing the AstraZeneca vaccine altogether on April 14 after initially suspending use. On Monday, Ritzau information company reported that authorities mentioned it could be attainable for individuals to have the vaccine if they want.
Will take extra time to evaluate whether or not to renew use of the vaccine. While Norway’s Institute of Public Health beneficial ending use of the shot, the federal government wants extra information earlier than making a closing name. Norway had suspended the rollout on March 11.
J&J VACCINE DELAYS AND RESTRICTIONS
On April 13, U.S. federal well being businesses beneficial pausing use of J&J’s COVID-19 vaccine for not less than a couple of days after six ladies underneath the age of fifty developed uncommon blood clots after receiving the shot.
On April 15, U.S. CDC advisory panel determined to delay a vote to April 23 on how finest to make use of the J&J shot.
AstraZeneca mentioned it might delay the rollout of the vaccine to Europe, after regulators mentioned they had been reviewing uncommon blood clots.
Widespread use within the EU had not but began after the corporate started delivering the doses within the week starting April 12. The European drug regulator beneficial storing doses already acquired till its security committee points an expedited advice
On April 15, Poland began administering the J&J shot with drug workplace representatives saying advantages outweigh potential dangers, whereas Belgium has delayed the beginning of vaccine administering on the firm’s request.
Suspended use of J&J’s vaccine on April 13.